The FDA has approved Alnylam’s gene silencing drug ... As the kidney function worsens, oxalate can build up and damage other organs including the heart, bones and eyes. The disease is also ...
26, when the U.S. Food and Drug Administration (FDA) approved Cobenfy for the psychiatric ... system as a possible treatment for Alzheimer’s disease, since manipulating it seemed to reduce ...
26, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved ... moderate or severe kidney or liver disease, gastric retention, untreated narrow-angle glaucoma or a history ...
Travere Therapeutics TVTX announced that the FDA granted ... immunosuppressive drug Filspari (sparsentan) in IgA nephropathy (IgAN) indication, a rare progressive kidney disease.
17, 2024 /PRNewswire/ -- Novartis today announced that the US Food and Drug ... disease-free survival (iDFS) benefit was consistently observed across all patient subgroups 3-6. "The FDA approval ...
Roughly 1 percent of Americans suffer from schizophrenia, which is one of the 15 leading causes of disability worldwide, the FDA reports ... or kidney disease. Even so, the drug offers a promising ...
The FDA says people with known liver impairment or moderate to severe kidney impairment should not use the drug. Summer Colling, a senior analyst at Citeline, says the novel muscarinic mechanism ...
For the first time in nearly three decades, a new treatment for schizophrenia has been approved by the U.S. Food and Drug Administration (FDA ... high rates of heart disease and premature ...
SILVER SPRING, Md., Sept. 26, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of ...
The regulator’s decision expands the drug’s indication to cover all patients who are at risk of disease progression The US Food and Drug Administration (FDA) has granted full approval to Travere ...
17, 2024 /PRNewswire/ -- Novartis today announced that the US Food and Drug ... "The FDA approval of Kisqali for this early breast cancer population, including those with N0 disease, is a pivotal ...
